Bonus Episode | 13 MAY 2021
Benefits of Neoadjuvant use of Mitomycin C for the Management of NMIBC
This episode, sponsored by medac, is a discussion around non-muscle-invasive bladder cancer (NMIBC). We hear from Professor Jørgen Bjerggaard Jensen, who leads clinical research in bladder cancer at the Department of Urology, Aarhus University Hospital, as he explores the management of NMIBC through the neoadjuvant use of Mitomycin C (MMC).
Spotify | Apple | Acast | Download MP3 (mp3, 29:48 mins)